U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H26N2O2
Molecular Weight 278.3898
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EVENAMIDE

SMILES

CCCCOC1=CC=CC(CCNCC(=O)N(C)C)=C1

InChI

InChIKey=GRHBODILPPXVKN-UHFFFAOYSA-N
InChI=1S/C16H26N2O2/c1-4-5-11-20-15-8-6-7-14(12-15)9-10-17-13-16(19)18(2)3/h6-8,12,17H,4-5,9-11,13H2,1-3H3

HIDE SMILES / InChI
Evenamide (NW-3509) is a blocker of voltage-gated sodium channels. Evenamide modulates sustained repetitive firing, without inducing impairment of normal neuronal excitability. It normalizes glutamate release induced by aberrant sodium channel activity. The potential benefits of the compound have been demonstrated in numerous preclinical models predictive of efficacy in psychiatric diseases, including models of psychosis such as amphetamine-induced hyperactivity, sensorimotor gating and information processing deficits (pre-pulse inhibition impairment induced by different stimuli), mania and depression. Evenamide is being evaluated in a Phase II trial as add-on treatment to 5HT2/D2 blocking antipsychotics in schizophrenic patients.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.4 µM [Ki]

Sample Use Guides

a Phase II, 4-week, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability, pharmacokinetics of single and multiple doses, and preliminary evidence of efficacy of a dose range (15 mg-20mg-25mg BID) of Evenamide (NW-3509) or placebo, in the US and India, in 90 schizophrenic patients currently on risperidone (2 mg/day or higher) or aripiprazole (10 mg/day or higher) who are still symptomatic, despite at least 4 weeks of treatment at a stable dose.
Route of Administration: Oral
Name Type Language
EVENAMIDE
INN   WHO-DD  
INN  
Official Name English
NW-3509
Common Name English
Evenamide [WHO-DD]
Common Name English
2-((2-(3-BUTOXYPHENYL)ETHYL)AMINO)-N,N-DIMETHYLACETAMIDE
Systematic Name English
ACETAMIDE, 2-((2-(3-BUTOXYPHENYL)ETHYL)AMINO)-N,N-DIMETHYL-
Systematic Name English
evenamide [INN]
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID101032897
Created by admin on Sat Dec 16 17:58:21 GMT 2023 , Edited by admin on Sat Dec 16 17:58:21 GMT 2023
PRIMARY
FDA UNII
ON5S6N53JS
Created by admin on Sat Dec 16 17:58:21 GMT 2023 , Edited by admin on Sat Dec 16 17:58:21 GMT 2023
PRIMARY
SMS_ID
300000025660
Created by admin on Sat Dec 16 17:58:21 GMT 2023 , Edited by admin on Sat Dec 16 17:58:21 GMT 2023
PRIMARY
INN
10101
Created by admin on Sat Dec 16 17:58:21 GMT 2023 , Edited by admin on Sat Dec 16 17:58:21 GMT 2023
PRIMARY
PUBCHEM
25105689
Created by admin on Sat Dec 16 17:58:21 GMT 2023 , Edited by admin on Sat Dec 16 17:58:21 GMT 2023
PRIMARY
CAS
1092977-61-1
Created by admin on Sat Dec 16 17:58:21 GMT 2023 , Edited by admin on Sat Dec 16 17:58:21 GMT 2023
PRIMARY
NCI_THESAURUS
C174804
Created by admin on Sat Dec 16 17:58:21 GMT 2023 , Edited by admin on Sat Dec 16 17:58:21 GMT 2023
PRIMARY
WIKIPEDIA
Evenamide
Created by admin on Sat Dec 16 17:58:21 GMT 2023 , Edited by admin on Sat Dec 16 17:58:21 GMT 2023
PRIMARY